The fund is rated 3 stars. Taken together, the fund's movement relative to its index and annual fee of 1.33% place it around the middle of similar funds.
This index fund/ETF has a beta of 0.869%, and an expense ratio of 1.33%, giving it a 3.0 star rating, based on the principle that lower values of |1-beta| and expense ratio result in higher ratings.
எங்கள் score நீண்டகால performance, risk மற்றும் consistency-ஐ மதிப்பிடுகிறது — past returns மட்டும் அல்ல.
5 Nov 2026 நிலவரப்படி
31 Oct 2026 நிலவரப்படி
30 Sep 2026 நிலவரப்படி
| Holding | Fund-இன் % | மதிப்பு | பங்குகள் |
|---|---|---|---|
| Castrol India Ltd. | 4.94% | ₹2.92 Cr | 1,45,954 |
| Others | 4.51% | ₹2.65 Cr | — |
| Marico Ltd. | 3.65% | ₹2.16 Cr | 27,432 |
| Abbott India Ltd. | 3.62% | ₹2.14 Cr | 789 |
| Apollo Hospitals Enterprise Ltd. | 3.48% | ₹2.06 Cr | 2,529 |
| ITC Ltd. | 3.47% | ₹2.05 Cr | 77,832 |
| Sun Pharmaceutical Industries Ltd. | 3.45% | ₹2.04 Cr | 11,215 |
| Bharti Airtel Ltd. | 3.42% | ₹2.02 Cr | 11,516 |
| NTPC Ltd. | 3.42% | ₹2.03 Cr | 62,907 |
| SBI Life Insurance Company Ltd. | 3.41% | ₹2.02 Cr | 11,935 |
Return that corresponds to the total returns of the S&P BSE Low Volatility Total Return Index subject to tracking error. Long term capital growth.
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by S&P BSE Low Volatility Total Return Index, subject to tracking error.
Exit load of 1% if redeemed within 15 days.
மியூச்சுவல் ஃபண்டுகள் சந்தை ஆபத்துகளுக்கு உட்பட்டவை. அனைத்து scheme documents-ஐ கவனமாகப் படிக்கவும்.
